CollabRx Teams With MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment

Published: Aug 08, 2012

PETALUMA, Calif.--(BUSINESS WIRE)--Tegal Corporation (NASDAQ: TGAL) today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder™ tool to MedPage Today, Everyday Health, Inc.’s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

Back to news